ALL pharmacies within the combined Terry White and Chemmart networks will be trading under the TerryWhite Chemmart brand by the end of 2017, according to an update issued yesterday by the company.
SIGMA Pharmaceuticals has made provision for a doubtful debt of around $8 million relating to a single pharmacy group (PD breaking news Fri), with the impact affecting the company's full year results to 31 Dec which will be released in a month's time.
CHEMIST Warehouse has signed an agreement with Medscope which will see the company's pharmCare professional services software platform roll out right across the national Chemist Warehouse network.
PRICELINE Pharmacy hosted The Beauty Prescription last Friday showcasing health and beauty expertise to more than 170 media representing a record potential audience of 39 million people.
RECENT changes to Queensland legislation mean that community pharmacies across Australia can now ensure the continued supply of some medicines to patients, according to an article in the latest Pharmacy Guild Forefront.
A BROAD cross-section of medical and health representatives, including the national vice president of the Pharmaceutical Society of Australia(PSA), have been appointed to the government's newly established Australian Advisory Council on the Medicinal Use of Cannabis.
THE Mental Health Commission of NSW has developed new resources for patients with a mental health concern, to be distributed to communities through over 2,000 pharmacies and neighbourhood centres this month.
THE $4.7 billion complementary medicines industry is "not going away, no matter how much its detractors huff and puff," according to Pharmacy Guild executive director David Quilty.
NEW Zealand's Medsafe regulatory agency has accepted a recommendation to change the classification of certain oral contraceptives from 'prescription' to 'restricted' medicines.
THE Therapeutic Goods Administration is seeking feedback on key reforms to the regulation of complementary medicines, with the aim of increasing transparency for consumers, providing additional flexibility for industry and supporting innovation - while maintaining the safety and quality of therapeutic goods in Australia.